Filing Flows › Ideaya Biosciences (IDYA) › Recalls, complaints & regulation
Ideaya Biosciences (IDYA): clinical trials
Ideaya Biosciences (IDYA) beyond its filings: 11 active clinical trials.
Ideaya Biosciences' latest quarter
Ideaya Biosciences, Q3 2026: revenue $10.2M (-95% year over year), net loss $126M, operating cash flow −$93.5M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Ideaya Biosciences have?
11 active studies on ClinicalTrials.gov, 3 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.